RECRUITING

Using PrEP, Doing It for Ourselves

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to test a new online program called UPDOs Protective Styles to help people in the southeastern United States learn about and start using PrEP (pre-exposure prophylaxis), a medicine that helps prevent HIV. The study focuses on people who may be at higher risk for HIV and have not had equal access to PrEP. The main questions it aims to answer are: Does UPDOs help more people trust and understand PrEP? Does UPDOs increase the number of people who start and continue using PrEP? Researchers will compare two groups: One group will use UPDOs, which includes six weekly videos, blog discussions, and access to telehealth services through Q Care Plus. The other group will receive standard HIV prevention materials from the CDC. Participants will: Be recruited from 32 beauty salons in areas with high HIV rates. Complete surveys at the start of the study and again at 6, 12, 24, 32, and 52 weeks. Have access to HIV testing and PrEP prescriptions through Q Care Plus. This study will also look at how well the program works in different communities and how easy it is to use and share.

Official Title

Cluster Randomized Controlled Trial of Using PrEP, Doing it for Ourselves [UPDOs] Protective Styles: A Multi-level Intervention to Improve HIV Testing and PrEP Uptake Among At-risk Populations Living in the Southeastern Region of the United States

Quick Facts

Study Start:2025-11
Study Completion:2030-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06638892

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Black
  2. * cisgender female
  3. * Ages 18+
  1. * Under 18 years of age
  2. * Does not identify as Black
  3. * Not a cisgender female

Contacts and Locations

Study Contact

Niasha Fray, MA, MSPH
CONTACT
919-668-8325
Niasha.Fray@Duke.edu
Schenita Randolph, PhD
CONTACT
919-684-3786
schenita.randolph@duke.edu

Principal Investigator

Schenita Randolph, PhD
PRINCIPAL_INVESTIGATOR
Duke University

Study Locations (Sites)

Duke University School of Nursing
Durham, North Carolina, 27710
United States

Collaborators and Investigators

Sponsor: Duke University

  • Schenita Randolph, PhD, PRINCIPAL_INVESTIGATOR, Duke University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-11
Study Completion Date2030-01

Study Record Updates

Study Start Date2025-11
Study Completion Date2030-01

Terms related to this study

Keywords Provided by Researchers

  • Black Women
  • Community-based Research

Additional Relevant MeSH Terms

  • HIV Prevention
  • PrEP